Рациональная фармакотерапия в кардиологии (Sep 2015)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)

  • R. Eschalier,
  • J.J.V. McMurray,
  • K. Swedberg,
  • D.J. Veldhuisen van,
  • H. Krum,
  • S.J. Pocock,
  • H. Shi,
  • J. Vincent,
  • P. Rossignol,
  • F. Zannad,
  • B. Pitt

DOI
https://doi.org/10.20996/1819-6446-2014-10-1-106-115
Journal volume & issue
Vol. 10, no. 1
pp. 106 – 115

Abstract

Read online

Translation articles:R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. van Veldhuisen, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt, for the EMPHASIS-HF Investigators “Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function. Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)” J Am Coll Cardiol 2013;62(17):1585-93; http://dx.doi.org/10.1016/j.jacc.2013.04.086